Bay Colony Advisors’s Regenxbio RGNX Stock Holding History

Bay Colony Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,400	Closed	-$253K	–	236
2019 Q4	$253K	Sell	5,400 -1,850	-26%	-$73.1K	0.16%	206
2019 Q3	$258K	Buy	7,250 +1,600	+28%	+$64.8K	0.18%	196
2019 Q2	$290K	Buy	+5,650	New	+$282K	0.19%	148
2018 Q3	–	Sell	-9,700	Closed	-$696K	–	744
2018 Q2	$696K	Buy	+9,700	New	+$463K	0.49%	50

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Bay Colony Advisors's RGNX Position: Q1 2020 in Review

Bay Colony Advisors sold out of Regenxbio (RGNX) in Q1 2020, closing a stake of 5,400 shares — an estimated $253K sold.

Bay Colony Advisors first reported a position in RGNX in Q2 2018 and held it in 4 quarters. The position peaked at $696K in Q2 2018. 170 funds tracked by Wall St. Rank hold RGNX as of Q1 2020.

Bay Colony Advisors reported no remaining Regenxbio position as of Q1 2020 after selling out during the quarter.
Bay Colony Advisors sold 5,400 Regenxbio shares in Q1 2020, an estimated $253K.
Bay Colony Advisors first reported a position in Regenxbio in Q2 2018 and held it in 4 quarters.
Bay Colony Advisors's Regenxbio position peaked at $696K in Q2 2018.
170 funds tracked by Wall St. Rank held Regenxbio as of Q1 2020.

Based on Bay Colony Advisors's 13F filing for Q1 2020, filed 17 Apr 2020.